| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mr. Jiazhang Lin CEO | TWSE Exchange | TW0006776008 ISIN |
| TW Country | - Employees | 25 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Established in 2014 and headquartered in New Taipei City, China, 3D Global Biotech Inc. specializes in innovating medical materials aimed at human body reconstruction. Utilizing advanced technologies such as cell culture systems, 3D printing, and bio-inks hydrogel, the company focuses on the development and production of customized autologous cell-based medical products. With a core mission to advance the field of human tissue and organ reconstruction, 3D Global Biotech Inc. is at the forefront of creating personalized medical equipment through comprehensive research. Catering to a diverse clientele, including medical centers, research institutions, and various distributors, the company is dedicated to fostering an interdisciplinary alliance that spans industry, government, academia, research, and medicine.